Headset Settles COVID Fraud Allegations for $1 Million
Cannabis data analytics firm agrees to pay federal settlement over allegedly fraudulent pandemic relief claims filed in 2020.

Focused image of business credit application papers, ideal for finance themes.
Settlement Terms and Admission
Headset will pay $1 million to the federal government under a civil settlement that closes a six-year investigation into pandemic relief applications filed in spring 2020. The company didn't admit wrongdoing as part of the agreement, according to a DOJ press release issued today. The settlement covers allegations that Headset misrepresented employee counts and payroll figures on applications for Paycheck Protection Program loans and an Economic Injury Disaster Loan administered by the Small Business Administration.
The False Claims Act permits the government to recover treble damages plus penalties when contractors or grant recipients knowingly submit false claims. The $1 million figure suggests the underlying loan amounts were substantially smaller. The settlement likely reflects a negotiated resolution rather than maximum statutory exposure.
Alleged Misrepresentations on Relief Applications
Federal investigators alleged that Headset inflated employee headcount and monthly payroll costs on PPP and EIDL applications submitted between March and June 2020. Both programs required applicants to certify the accuracy of workforce and financial data under penalty of perjury. The SBA's PPP formula tied loan amounts directly to reported average monthly payroll, creating an incentive to overstate labor costs.
Headset operates in a capital-intensive sector—cannabis market intelligence and point-of-sale data aggregation—where payroll is typically a smaller percentage of operating costs than in labor-heavy retail or cultivation. Its core product? A subscription analytics platform used by MSOs and single-state operators, relying on software engineering and data science teams rather than large hourly workforces.
The settlement doesn't specify which loan programs Headset accessed or the original loan amounts received. PPP loans under $150,000 were eligible for streamlined forgiveness; larger loans required detailed documentation of payroll maintenance and employee retention.
Headset's Market Position and Client Base
Headset serves more than 2,000 cannabis retailers and brands across North America, providing real-time sales data, market share analytics, and consumer trend reporting. The platform aggregates anonymized point-of-sale data from dispensaries in legal markets including California, Colorado, Washington, Oregon, Illinois, and Ontario. Clients use the service to benchmark performance, optimize product assortment, and track category growth.
In 2019, the company raised a $12 million Series A round and expanded aggressively in 2020 and 2021 as new adult-use markets came online. Headset competes with BDS Analytics (now part of Kynetec) and other cannabis data providers in a fragmented market intelligence sector. Unlike cultivators or retailers, data firms faced minimal pandemic-related revenue disruption. Dispensaries remained open as essential businesses in most jurisdictions, and POS transaction volume surged in Q2 2020.
The cannabis data sector saw record transaction volumes during lockdowns, raising questions about whether firms like Headset met the "economic uncertainty" threshold that justified emergency relief access.
Broader Pattern of PPP Fraud Enforcement
The DOJ has recovered more than $1.4 billion in COVID relief fraud settlements since 2021, with cannabis-touching businesses representing a small but visible subset of enforcement actions. Most cannabis PPP cases have involved retail operators or cultivation facilities that allegedly inflated payroll or misrepresented ownership structures to evade the SBA's initial guidance excluding federally illegal businesses.
Key enforcement patterns include:
- Misrepresentation of employee counts or wage levels to maximize loan amounts
- Failure to disclose criminal histories or ownership stakes that would disqualify applicants
- Use of relief funds for non-payroll purposes, violating forgiveness terms
- Submission of falsified tax documents or payroll records during audits
The SBA explicitly barred "direct marijuana businesses" from PPP eligibility in April 2020 guidance, but ancillary service providers—including software firms, testing labs, and consultancies—remained eligible if they didn't directly handle cannabis. Headset's business model involves data aggregation rather than plant-touching operations. That likely placed it in the eligible category. The fraud allegations hinge on financial misrepresentation rather than categorical ineligibility.
What Comes Next for Headset
Headset remains operational and hasn't disclosed whether the settlement will affect its capital structure or client relationships. The company hasn't issued a public statement beyond confirming the settlement terms. No criminal charges were filed. No individual executives were named in the civil action.
For context on how pandemic relief enforcement is playing out across the cannabis sector, see the CannIntel topic hub on Headset's COVID fraud settlement. The SBA's Office of Inspector General continues to audit high-dollar PPP loans, with a focus on industries that experienced revenue growth during lockdowns. Data firms, e-commerce platforms, and delivery services remain under scrutiny for certifications of "economic necessity" that may not align with 2020 financial performance.
Frequently asked questions
What did Headset allegedly do wrong?
Federal investigators alleged that Headset misrepresented employee headcount and monthly payroll costs on Paycheck Protection Program and Economic Injury Disaster Loan applications submitted in spring 2020. The company settled False Claims Act allegations for $1 million without admitting wrongdoing.
Was Headset eligible for COVID relief as a cannabis business?
Yes. The SBA barred "direct marijuana businesses" from PPP eligibility, but ancillary service providers like data analytics firms remained eligible. Headset's software platform doesn't involve plant-touching operations, placing it in the eligible category. The fraud allegations center on financial misrepresentation, not categorical ineligibility.
Will Headset face criminal charges?
No. The $1 million settlement resolves civil allegations under the False Claims Act. No criminal charges were filed, and no individual executives were named in the DOJ action. Headset remains operational.
How common is PPP fraud enforcement in cannabis?
The DOJ has recovered more than $1.4 billion in COVID relief fraud settlements across all sectors since 2021. Cannabis-touching businesses represent a small but visible subset, with most cases involving retailers or cultivators that allegedly inflated payroll or misrepresented ownership to evade eligibility restrictions.
What is Headset's role in the cannabis industry?
Headset provides real-time sales data and market analytics to more than 2,000 cannabis retailers and brands across North America. The platform aggregates anonymized point-of-sale data from dispensaries, enabling clients to benchmark performance and track consumer trends in legal markets.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Humboldt Merchant Services Settles FTC Fraud Claims for $12M
Federal regulators allege the cannabis payment processor opened over 1,000 sham merchant accounts tied to fraudulent billing schemes.

NOLA Cannabis Co. Opens Bourbon Street Flagship in New Orleans
The Louisiana dispensary operator launches a 3,200-square-foot retail store in the French Quarter, targeting tourist and local foot traffic.

Federal Report Shows Banks Still Reject Cannabis Clients Despite SAFER
New federal data reveals persistent banking access gaps for marijuana businesses even as legislative momentum stalls.
More from the newsroom

Colorado Regulators Face Criticism Over Delayed Adverse-Effect Warnings
State cannabis officials delayed public warnings about reported adverse reactions to regulated products, drawing scrutiny over consumer-safety protocols.

Ohio Dispensary Voluntarily Closes Amid State Health Investigation
An unnamed Ohio dispensary shut its doors voluntarily as state regulators investigate reports of adverse health events linked to products sold at the location.

Six States Report Marijuana Arrests Exceed Half of All Drug Arrests
New federal data shows cannabis enforcement still dominates drug arrests in Wyoming, Montana, Nebraska, Iowa, Kansas, and South Dakota despite shifting national policy.